Company profilePharmaceutical#792 of 1,318 in Pakistan✓ No DRAP alerts

ANGELINI PHARMACEUTICALS (PVT) LTD

Pharmaceutical company · 10 brands · 11 molecules

Ranked #3 of 4 companies in Throat Preparations

10 registered products 12 pharmaceutical brands 11 distinct molecules 0 DRAP alerts

Company overview

10
registered products
12
pharmaceutical brands
11
distinct molecules
9
therapeutic classes
0
DRAP alerts

ANGELINI PHARMACEUTICALS (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 10 product registrations across 11 distinct molecules. Its portfolio is concentrated in Throat Preparations and Fever/Flu/Cough. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ANGELINI

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Anti-Infectives 1

Top molecules by brand count

Benzydamine2 brands
Ketoprofen Topical1 brand
Fosfomycin1 brand
Vaginal1 brand

Therapeutic classes

Throat Preparations · 2Fever/Flu/Cough · 1Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1Topical Products For Joint And Muscular Pain · 1Antispasmodic & Anticholinergic · 1Other Bacterial And Viral Vaccines · 1Anti-Infectives · 1Muscle Relaxant · 1Gynaecological Anti-Infective & Antiseptics · 1

Conditions treated

Expectorant · 1General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid2 products · Rs 469.2 – Rs 775.18
Median across source: Rs 622.19

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

SHROOQ PHARMACEUTICALS6 shared molecules
LINTA4 shared molecules
VALOR PHARMACEUTICALS4 shared molecules
TABROS PHARMA (PVT). LTD.3 shared molecules
PharmEvo Private Limited3 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SHROOQ PHARMACEUTICALS holds 22 molecules not in this portfolio
AcitretinAcyclovirAcyclovir Inf/OralCefiximeCiprofloxacinDiclofenac
PLATINUM PHARMACEUTICALS (PVT.) LTD. holds 124 molecules not in this portfolio
AlfacalcidolAmlodipineAmlodipine Base 10MgAmlodipine Base………….5MgAripiprazoleArtemether
LINTA holds 2 molecules not in this portfolio
DoxazosinEtoricoxib

Get the full profile for ANGELINI

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.